PPMD Invests $400,000 in MyoGene Bio to Advance Gene Editing Research#USA#San_Diego#Duchenne_MD#MyoGene_Bio#PPMD_Venture
PPMD Invests $400,000 in MyoGene Bio to Advance Gene Editing Research
The Parent Project Muscular Dystrophy has secured $400,000 in funding for MyoGene Bio, significantly advancing research on Duchenne muscular dystrophy using gene editing technology.
third-news.com
November 4, 2025 at 4:56 PM
PPMD Invests $400,000 in MyoGene Bio to Advance Gene Editing Research#USA#San_Diego#Duchenne_MD#MyoGene_Bio#PPMD_Venture